3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
13
Carcinoma, Non-Small-Cell Lung
13
Carcinoma, Hepatocellular
6
Adenocarcinoma
6
Neoplasms
5
Lung Neoplasms
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Breast Neoplasms
4
Urethral Neoplasms
3
Rectal Neoplasms
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Carcinoma, Renal Cell
3
Urinary Bladder Neoplasms
2
Ureteral Neoplasms
2
Solid Tumors
2
Sarcoma
2
Non-small Cell Lung Cancer Metastatic
2
Malignant Solid Tumor
2
Esophageal Neoplasms
2
Carcinoma, Transitional Cell
2
Biliary Tract Neoplasms
2
Thymoma
1
Solid Tumor
1
Sarcoma, Synovial
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Interventions
pazopanib
2
cediranib
2
Sunitinib
2
Ifosfamide
2
Doxorubicin
2
sargramostim
1
romidepsin
1
pembrolizumab
1
indolepropanol phosphate
1
cabozantinib
1
atropine sulfate-diphenoxylate hydrochloride drug combination
1
Watchful Waiting
1
Warfarin
1
Vitamin B 6
1
Thyroxine
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiotherapy
1
Radiation
1
Pyridoxine
1
Promethazine
1
Prochlorperazine
1
Polymerase Chain Reaction
1
Petrolatum
1
Observation
1
Neoadjuvant Therapy
1
Lorazepam
1
Loperamide
1
HhAntag691
1
Gene Expression Profiling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Sarcoma, Alveolar Soft Part
×
Ramucirumab
×
Clear all
No trials found.